ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014

Senate Resolution Urges CMS To Reopen Coverage Policy on ESAs In Oncology.

September 7, 2007

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010

In Brief: Relocation Of NCI Offices Nearly Complete; Hungary’s Eckhardt UICC President elect

November 4, 1988